About Paragon Intellectual Properties
Nexeon MedSystems is committed to improving lives through the development of therapies for people with cardiovascular disease. With proven medical device research and development talent, a strong intellectual property portfolio and the leadership of a veteran interventional cardiologist, Nexeon has created an pipeline of products for unmet clinical needs.
Latest Paragon Intellectual Properties News
Nov 29, 2016
Advertisement Topics Track topics on Twitter Track topics that are important to you Printed From BioPortfolio.com Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 22:26 EST 28 Nov 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC since January 2007. Key Findings Provides intelligence on Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC and its subsidiaries since 2007. Information about key financial and legal advisors for Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC's financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC's growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News
Paragon Intellectual Properties Frequently Asked Questions (FAQ)
When was Paragon Intellectual Properties founded?
Paragon Intellectual Properties was founded in 2004.
What is Paragon Intellectual Properties's latest funding round?
Paragon Intellectual Properties's latest funding round is Other Investors.
Who are the investors of Paragon Intellectual Properties?
Investors of Paragon Intellectual Properties include SurModics.
Who are Paragon Intellectual Properties's competitors?
Competitors of Paragon Intellectual Properties include HistoSonics, Aethlon Medical, Mercator MedSystems, Sonivate Medical, Valtech Cardio and 11 more.
Compare Paragon Intellectual Properties to Competitors
HistoSonics develops a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquefy unwanted tissue and tumors at sub-cellular levels. The company is focused on the development of its Edison platform, combining imaging with sensing technology to deliver personalized external beam treatments with precision and control, reducing the side effects of conventional therapies. The company was founded in 2009 and is based in Minneapolis, Minnesota.
ADVOS is a combined multi-organ support system for liver, lung, kidney, and acid-base balance. Based on the principle of albumin dialysis, ADVOS allows both extracorporeal elimination of CO2, hepatic toxins, and water-soluble & protein-bound nephrotoxins, as well as the correction of metabolic and respiratory acidosis. The ADVOS procedure works with dialysis-usual access and flow rates and does not require a gas exchanger for CO2 elimination.
Aethlon Medical is the developer of the Hemopurifier - medical device that aims to treat infectious disease.
Magneceutical Health is in the Complementary and Alternative Medicine market, and is dedicated to helping people improve their health and wellness by enhancing relaxation through the use of natural and holistic magnetic fields.
Carticept Medical is a medical device-developing company. It provides solutions for patients with osteoarthritis and cartilage damage. It offers products to address the shortcomings of the current conservative and surgical treatment options for osteoarthritis and cartilage injuries such as ultrasound products, computer-controlled infusion systems, and a medical device to replace and repair worn and damaged cartilage. Carticept Medical was formerly known as Windward Medical. The company was founded in 2005 and is based in Alpharetta, Georgia.
The company's goal is to develop medical devices to improve care for people with serious diseases. The current focus aims to provide medical researchers with an effective, flexible means to develop treatments and diagnosis through the use of microbubbles. Microbubbles are a proven medical product used to enhance ultrasound imaging. Researchers and physicians are beginning to demonstrate the enormous potential of ultrasound and microbubble enhanced therapies " please see resources for a list of publications. Artenga's medical device is annon-demand system to generate microbubbles optimized for therapy.